Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
Postprandial hyperglycemia causes lifestyle-related diseases such as diabetes and obesity. In this study, we identified Enterococcus faecalis YM0831 strain that suppresses postprandial hyperglycemia in silkworms. E. faecalis YM0831 inhibited glucose permeability in the isolated intestinal tract of silkworm and glucose uptake by Caco-2 cells, derived from the human intestine. In a human clinical trial, E. faecalis YM0831 suppressed an increase in blood glucose level in a sucrose tolerance test. These results suggest that E. faecalis YM0831 inhibits sugar uptake in human intestine and prevents postprandial hyperglycemia in humans.
|